• Mashup Score: 0

    Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.

    Tweet Tweets with this article
    • Experts in this @AJMC_Journal #StakeholderSummit series discuss #clinical and #financial concerns related to automatic substitution for an interchangeable #biosimilar from a payer perspective. Watch here: https://t.co/IQgZAAHUeA https://t.co/Ckdgtzh2u4

  • Mashup Score: 0

    August 8, 2023 — More adolescents and teens are developing health conditions that may increase their risk of premature cardiovascular disease in adulthood, therefore, early screening, diagnosis and multidisciplinary care are vital. A new survey of cardiovascular care centers in the U.S. and Canada found that there are not enough resources to meet the needs for pediatric preventive cardiology care, and the survey results are detailed in a new American Heart Association science advisory, published today in the Association’s journal Circulation: Cardiovascular Quality & Outcomes.  The advisory is the first to address the status of pediatric preventive cardiology (PPC) programs in the U.S. and Canada and present a roadmap for the future of the field.  It reports that 39% of U.S. youth ages 12-19 are diagnosed as having overweight or obesity, 53% have abnormal lipids, 18% have prediabetes and 15% have elevated blood pressure. Children with these conditions have an increased risk of having a

    Tweet Tweets with this article
    • @DAICeditor @American_Heart A new #AmericanHeartAssociation science advisory urges #clinical care guidelines for youth, and for hospitals, payers and policymakers to help meet the need for best practices in #pediatric preventive #cardiovascular care: https://t.co/x2tZ9Mz834

  • Mashup Score: 0

    July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical protocol for cardiovascular computed tomography (CCT) to guide intervention in the right ventricular outflow tract (RVOT) in patients with congenital heart disease (CHD).  “Technical Recommendations for Computed Tomography Guidance of Intervention in the Right Ventricular Outflow Tract: Native RVOT, Conduits and Bioprosthetic Valves” offers imaging and reporting standards for surgical or transcatheter pulmonary valve replacement (TPVR), including dysfunctional RVOT conduits and bioprosthetic valves, as well as native and patched RVOTs.  The goal of the multi-specialty collaboration of three contributing societies – SCCT, the Society for Cardiovascular Angiography and Intervention (SCAI), and the Congenital Heart Surgeons’ Society (CHSS) – is to optimize CCT image acquisition, minimize diagnostic risk and standardize reporting to guide pulmonary valve replacement (PVR), a

    Tweet Tweets with this article
    • @DAICeditor @Heart_SCCT A new expert consensus from #SCCT offers #clinical protocol for #cardiovascular #computedtomography (CCT) to guide intervention in the right ventricular outflow tract (#RVOT) in patients with congenital heart disease (CHD): https://t.co/U7HQeOVNVO #scct23

  • Mashup Score: 1

    June 27, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) has released an expert consensus document standardizing medical terminology commonly used in clinical and research activities related to cardiac computed tomography (CT), providing an update to guidance published 12 years ago by the society in the Journal of Cardiovascular Computed Tomography (JCCT). “Standardized Medical…

    Tweet Tweets with this article
    • @DAICeditor @Heart_SCCT #SCCT has released an expert consensus document standardizing medical terminology commonly used in #clinical and #research activities related to #cardiac #computedtomography (#CT): https://t.co/Ee4t3JP6aK

  • Mashup Score: 0

    June 22, 2023 — Cassling has announced a partnership with the goal of benefiting cardiovascular practices throughout the United States.  Cassling will act as a sales agent for EchoSolv, a revolutionary new cloud-based software from Echo IQ, an AI healthtechcompany. EchoSolv, a proprietary artificial intelligence clinical decision support platform, supports cardiology practitioners in diagnosing…

    Tweet Tweets with this article
    • @DAICeditor @CasslingTweets @EchoSolv The Midwest company will begin offering EchoSolv, an #ArtificialIntelligence #clinical decision support platform designed to help detect severe #aortic #stenosis, to providers throughout the country: https://t.co/1ElhwNOK11